BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29132054)

  • 1. Contrast-enhanced imaging features and differentiation of benign and malignant focal splenic lesions.
    Cao F; Qian W; Ma Y; Wu Y; Zhong J
    Clin Imaging; 2018; 49():58-64. PubMed ID: 29132054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
    Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
    Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CT in Differentiating Malignant Focal Splenic Lesions.
    Jang S; Kim JH; Hur BY; Ahn SJ; Joo I; Kim MJ; Han JK
    Korean J Radiol; 2018; 19(5):930-937. PubMed ID: 30174483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions.
    Ramani M; Reinhold C; Semelka RC; Siegelman ES; Liang L; Ascher SM; Brown JJ; Eisen RN; Bret PM
    Radiology; 1997 Jan; 202(1):166-72. PubMed ID: 8988207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.
    Jang KM; Kim SH; Hwang J; Lee SJ; Kang TW; Lee MW; Choi D
    AJR Am J Roentgenol; 2014 Oct; 203(4):803-12. PubMed ID: 25247945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic MR imaging of splenic tumor.
    Hayasaka K; Tanaka Y; Kawamori J
    Comput Med Imaging Graph; 1997; 21(4):243-51. PubMed ID: 9402237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cross-sectional imaging features that aid in the differentiation of benign and malignant splenic lesions.
    Abrishami A; Khalili N; Kooraki S; Abrishami Y; Grenacher L; Kauczor HU
    Eur J Radiol; 2021 Mar; 136():109549. PubMed ID: 33465552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nontraumatic focal splenic lesions using contrast-enhanced sonography.
    Chiavaroli R; Grima P; Tundo P
    J Clin Ultrasound; 2011 Jul; 39(6):310-5. PubMed ID: 21544827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhanced sonographic assessment of feeding vessels as a discriminator between malignant vs. benign focal splenic lesions.
    Taeymans O; Penninck D
    Vet Radiol Ultrasound; 2011; 52(4):457-61. PubMed ID: 21470337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the spleen: CT with supplemental MR examination.
    Rabushka LS; Kawashima A; Fishman EK
    Radiographics; 1994 Mar; 14(2):307-32. PubMed ID: 8190956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential echogenic focal splenic lesion diagnosis].
    Köhler M; Kubale R
    Praxis (Bern 1994); 2003 May; 92(22):1037-42. PubMed ID: 12830667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomographic imaging of the spleen: the role of morphological and metabolic features in differentiating benign from malignant diseases.
    Mainenti PP; Iodice D; Cozzolino I; Segreto S; Capece S; Sica G; Magliulo M; Ciancia G; Pace L; Salvatore M
    Clin Imaging; 2012; 36(5):559-67. PubMed ID: 22920362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time contrast-enhanced ultrasound in diagnosing of focal spleen lesions.
    Yu X; Yu J; Liang P; Liu F
    Eur J Radiol; 2012 Mar; 81(3):430-6. PubMed ID: 21273021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation.
    Abbott RM; Levy AD; Aguilera NS; Gorospe L; Thompson WM
    Radiographics; 2004; 24(4):1137-63. PubMed ID: 15256634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Pseudotumor-like Follicular Dendritic Cell Tumor of the Spleen: Case Report and Review of the Literature.
    Kitamura Y; Takayama Y; Nishie A; Asayama Y; Ushijima Y; Fujita N; Morita K; Baba S; Kubo Y; Shirabe K; Honda H
    Magn Reson Med Sci; 2015; 14(4):347-54. PubMed ID: 25740238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-center study: The diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing focal splenic lesions compared to CT and MRI.
    Schwarze V; Lindner F; Marschner C; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2019; 73(1):65-71. PubMed ID: 31561333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound pattern of splenic metastases - a retrospective study in 32 patients.
    Neesse A; Huth J; Kunsch S; Michl P; Bert T; Tebbe JJ; Gress TM; Görg C
    Ultraschall Med; 2010 Jun; 31(3):264-9. PubMed ID: 19899027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spleen: an integrated imaging approach.
    Rolfes RJ; Ros PR
    Crit Rev Diagn Imaging; 1990; 30(1):41-83. PubMed ID: 2405881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.